Long-term follow-up of patients with chronic hepatitis c after interferon-alpha treatment

Digestion

Volumn 57, Issue 6, 1996, Pages 464-471

  Gerlinde, Teuber ^a   Dienes, Hans Peter ^b   Meyer zum Büschenfelde, Karl Hermann ^a   Gerken, Guido ^a  

^a Abteilung Innere Medizin I   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Chronic hepatitis C; Interferon treatment; Long term follow up

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; DIAGNOSTIC VALUE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; VIRUS DETECTION;

ADULT; AGED; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL;

EID: 0029837142     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000201375     Document Type: Article

References (30)

1. Yousuf M, Nakano Y, Tanaka E, Sodevania T, Kiyosawa K: Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up. Scand J Gastroenterol 1992:27:812- 816
2. Tong MJ, Nccven S, El Farra NS, Reikcs AR, Co RL: Clinical outcome after transfusion-associated hcpatitisC. N Engl J Med 1995:322: 1463-1466.
3. Davis GL, Baiart LA, Schiff ER, Lindsay K, Bodenhcimer HC, Perillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowiteh J, Albrecht J, Me-schievitz C, Ortego TJ, Gibas A, The Hepatitis Interventional Therapy Group: Treatment of chronic hepatitis C with recombinant interferon alpha, A multicenter, randomized, controlled trial. N Engl J Med 1989:321:1501-1506.
4. Di Bisceglie AM, Martin P, Kassianides C, Liskcr-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JLL: Recombinant interferon alpha therapy for chronic hepatitis C. N Engl J Med 1989:321:1506- 1510.
5. Marcellin P, Boyer N, Giostra E, Degott C, Courouce AM, Degos F, Coppere H, et al: Recombinant human alpha-interfcron in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from France. Hepatologv 1991:13:393-397.
6. Chayama K, Saitoh S, Arase Y, Ikeda K, Mal-sumoto T, Sakai Y, Kobvashi M, Unakami M, Morinaga T, Kumada H: Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hcp-atology 1991:13:1040-1043.
7. Balart LA, Perillo RP, Roddenberry J, Regen-stcin F, Shim KS, Shieh YSC, Taylor B, Dash S, Gerber M: Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon alpha treatment. Gastroenterology 1993:104:1472-1477.
8. Battezzati PM, Podda M, Bruno S, Zuin M, Crosignani A, Camisasca M, Chiesa A, Pctroni ML, Russo A, Gallotti P, Borzio M, Borzio F, Buscarini L, Fomari F, Sbolli G, Lanzini A, Pigozzi MG, Salmi A, Dastoli G, Carriero PL: Factors prediciting early response to treatment with recombinant interferon alpha-2a in chronic non-A, non-B hepatitis, Preliminary report of a long term trial. Ital J Gastroenterol 1992;24:481-484.
9. Jouet P, Roudot-Thoraval F, Dhumeaux D, Mctreau JM, Le Groupe Français Pour l’Etude du Traitement des hépatites chroniques NANB/C: Comparative efficacy of interferon alpha in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Gastroenterology 1994;106:686-690.
10. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lcmonnier C, Trepo C, Couzigou P, Payen JL, Sajus M, Costa JM, Vidaud M, Chaput JC, the Multicenter Study Group: A comparison of three interferon alpha-2b regimens for the longterm treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995:332:1457-1462.
11. Hagiwara H, Havashi N, Fusamoto H, Ka-mada T: Quantitative analysis of hepatitis C virus RNA: Relationship between the replication level and the various stages of the carrier states or the response to interferon therapy. Gastroenterol Jpn 1993;28(suppl 5):48-51.
12. Lau JYN, Davis GL, KnifTen J, Qian KP, Urdea MS, Chan CS, Miz, okami M, Neuwald PD, Wilber JC: Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501-1504.
13. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kol-berg J, Urdea MS: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-2399.
14. Shindo M, Di Bisceglie AM, Hoofnagle JH: Long-term follow-up of patients with chronic hepatitis C treated with a-interfcron. Hepatolo-gy 1992;15:1013-1016.
15. Kakumu S, Yoshika K, Tanaka K, Higashi Y, Kurokawa S, Hirofuji H, Kusakabe A: Longterm carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C. J Med Virol 1993:41:65-70.
16. Saracco G, Rosina F, Abate ML, Chiandussi L, Gallo V, Cerutti E, Di Napoli A, Solinas A, Deplano A, Tocco A, Cossu P, Chicn D, Kuo G, Polito A, Weiner AJ, Houghton M, Verme G, Bonino F, Rizetto M: Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-a2b. Hepa-tologv 1993:18:1300-1305.
17. Castillo I, Bartolome J, Navas S, Gonzales S, Montserrat H, Carreno V: Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon. Hcpatology 1994;19:1342-1346.
18. Hof U, Kiither S, König V, Heult H, Berg T, Bauditz J, Soltani K, Lobeck H, Huhn D: Lang-zcitrachbcobachtung der chronischen Hepatitis C nach Behandlung mit rckombinantem Interferon alpha-2a. Z Gastroenterol 1994:32: 425-430.
19. Destnet VJ, Gerber M, Hoofnaglc JH, Manns M, Scheuer P: Classification of chronic hepatitis: Diagnosis, grading and staging. Hcpatology 1994:19:1513-1520.
20. Pugh RNH, Murray-Lyon 1M, Dawson JL, Pic-troni MC, Williams R: Transsection of the oesophagus for bleeding for oesophageal varices. Br J Surg 1973:60:646-649.
21. Zeuzent S, Riistcr B, Roth WK: Clinical evaluation of a new polymerase chain reaction assay (Amplicor™ HCV) for detection of hepatitis C virus. Z Gastroenterol 1994;32:342-347.
22. R HCV detection system. Klin Lab 1994:40:991-997.
23. van Doom L, van Ba MG, Quint W, Kos T, Schellekens H: Hepatitis C vims antibody detection by a line immunoassay and (near) full length genomic RNA detection by a new RNA-capture polymerase chain reaction. J Med Virol 1992:38:298-304.
24. Goergen G, Jakobs S, Symmons P, Homes E, Meyer zum Biischcnfclde KH, Gerkcn G: Quantitation of HCV-replication using onc-step competitive RT-PCR and a solid phase, colorimetric detection method. J Hepatol 1994:21:678-682.
25. Liskcr-Mclman M, Di Bisccglie AM, Usala SJ, ct al: Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology 1992; 102:2155- 2160.
26. Gross U, Seifert E: Passagerer insulinpflichti-gcr Diabetes mellitus unter Alpha-Intcrfcron-thcrapic bei chronisch aktiver Hepatitis. Z Gastroenterol 1993;31:609-611.
27. Diu JY, Mizokami M, Olino T, Diamond DA, Kniffen J, Davis GL: Discrepancy between biochemical and virological responses to interferon-« in chronic hepatitis C. Lancet 1993:342: 1208-1209.
28. Brillanti S, Foli M, Gaiani S, Masci C, Miglioli M, Barbara L: Persistent hepatitis C viraemia without liver disease. Lancet 1993:341:464-465.
29. Alberti A, Morisca G, Chemcllo L, Cavalletto D, Noventa F, Ponlisso P, Ruol A: Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992:340: 697-698.
30. McOmish F, Yap PL, Dow BC, Follett EAC, Seed C, Keller AJ, Cobain TJ, Krusius T, Kol-ho E, Naukkarincn R, Lin C, Lai C, Lcong S, Mcdgyesi GA, Héjjas T, Kiyokawa H, Fukada K, Cuypcrs T, Saecd AA, Al-Rasheed AM, Lin M, Simmonds P: Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey. J Clin Microbiol 1994:32:884-892